ArticleJAMA network open2024

Clinical Benefit, Price, and Regulatory Approval of Cancer Drugs Granted Breakthrough Therapy Designation in China, 2020-2024.

Xingxian Luo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.